{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:58:45Z","timestamp":1792403925032,"version":"4.4.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.radonc.2025.110775","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T02:43:01Z","timestamp":1738809781000},"page":"110775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Dose response relation for optic nerve atrophy at low-dose rate brachytherapy of uveal melanoma"],"prefix":"10.1016","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3218-0539","authenticated-orcid":false,"given":"Maja","family":"Guberina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stuschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0736-8946","authenticated-orcid":false,"given":"Dirk","family":"Fl\u00fchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7370-5077","authenticated-orcid":false,"given":"Leyla","family":"Jabbarli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4201-1296","authenticated-orcid":false,"given":"Tobias","family":"Kiefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5941-1686","authenticated-orcid":false,"given":"Eva","family":"Biewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3621-9007","authenticated-orcid":false,"given":"Philipp","family":"Rating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2542-438X","authenticated-orcid":false,"given":"Henning","family":"Manke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Dalbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nika","family":"Guberina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"P\u00f6ttgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miltiadis","family":"Fiorentzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Foerster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4909-1129","authenticated-orcid":false,"given":"Tobias","family":"Grunewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Bornfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5027-5913","authenticated-orcid":false,"given":"Wolfgang","family":"Sauerwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0180-1112","authenticated-orcid":false,"given":"Nikolaos","family":"Bechrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Sokolenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.radonc.2025.110775_b0005","first-page":"106","article-title":"The interdisciplinary diagnosis and treatment of intraocular tumors","volume":"115","author":"Bornfeld","year":"2018","journal-title":"Deutsches Arzteblatt Int"},{"issue":"5","key":"10.1016\/j.radonc.2025.110775_b0010","first-page":"304","article-title":"The collaborative ocular melanoma study: an overview","volume":"11","author":"Margo","year":"2004","journal-title":"Cancer Control J Moffitt Cancer Center"},{"key":"10.1016\/j.radonc.2025.110775_b0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000328254","article-title":"Ruthenium-106 brachytherapy","volume":"49","author":"Pe'er","year":"2012","journal-title":"Dev Ophthalmol"},{"issue":"2","key":"10.1016\/j.radonc.2025.110775_b0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/eye.2012.249","article-title":"Effects of radiotherapy on uveal melanomas and adjacent tissues","volume":"27","author":"Groenewald","year":"2013","journal-title":"Eye (Lond)"},{"issue":"4","key":"10.1016\/j.radonc.2025.110775_b0025","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10792-022-02527-8","article-title":"Vision-related quality of life amongst patients with low vision and blindness in a resource-limited country","volume":"43","author":"Asimadu","year":"2023","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.radonc.2025.110775_b0030","unstructured":"Finger PT PA, Sauerwein WAG. Intraocular Melanoma. In: DeVita VT Jr., Rosenberg SA, Lawrence TS(eds). DeVita, Hellman & Rosenberg\u2019s Cancer: Principles & Practice of Oncology, 12th Edition. Chapter 78. Philadelphia: Wolters Kluwer, 2022."},{"issue":"6","key":"10.1016\/j.radonc.2025.110775_b0035","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/bjo-2022-322854","article-title":"Radiation-induced optic neuropathy: a review","volume":"107","author":"Carey","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"5-6","key":"10.1016\/j.radonc.2025.110775_b0040","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000533426","article-title":"Radiation optic neuropathy: management options","volume":"9","author":"Oakey","year":"2023","journal-title":"Ocular Oncol Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.radonc.2025.110775_b0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000506415","article-title":"Anticoagulation for Radiation-Induced Optic Neuropathy","volume":"12","author":"Venketasubramanian","year":"2020","journal-title":"Case Rep Neurol"},{"issue":"3 Suppl","key":"10.1016\/j.radonc.2025.110775_b0050","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ijrobp.2009.07.1753","article-title":"Radiation dose-volume effects of optic nerves and chiasm","volume":"76","author":"Mayo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.radonc.2025.110775_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijrobp.2018.01.053","article-title":"Single- and multi-fraction stereotactic radiosurgery dose tolerances of the optic pathways","volume":"110","author":"Milano","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.radonc.2025.110775_b0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3171\/jns.1998.88.1.0043","article-title":"Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery","volume":"88","author":"Leber","year":"1998","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.radonc.2025.110775_b0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.semradonc.2015.11.008","article-title":"Dose-response modeling of the visual pathway tolerance to single-fraction and hypofractionated stereotactic radiosurgery","volume":"26","author":"Hiniker","year":"2016","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"10.1016\/j.radonc.2025.110775_b0070","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijrobp.2013.06.2047","article-title":"Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery","volume":"87","author":"Leavitt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.radonc.2025.110775_b0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semradonc.2008.04.001","article-title":"An overview of hypofractionation and introduction to this issue of seminars in radiation oncology","volume":"18","author":"Timmerman","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110775_b0080","article-title":"Treatment-related complications and functional results after ruthenium-106 brachytherapy in small to medium size uveal melanomas (Part 2)","author":"Lalos","year":"2024","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"key":"10.1016\/j.radonc.2025.110775_b0085","article-title":"Tumor- and radiation-related complications after ruthenium-106 brachytherapy in small to medium uveal melanomas (Part 1)","author":"Lalos","year":"2024","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"issue":"19","key":"10.1016\/j.radonc.2025.110775_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194729","article-title":"Feasibility, method and early outcome of image-guided volumetric modulated Arc radiosurgery followed by resection for AJCC Stage IIA-IIIB high-risk large intraocular melanoma","volume":"14","author":"Guberina","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.radonc.2025.110775_b0095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/09553008514550461","article-title":"An 'incomplete-repair' model for survival after fractionated and continuous irradiations","volume":"47","author":"Thames","year":"1985","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"issue":"1","key":"10.1016\/j.radonc.2025.110775_b0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0360-3016(00)00810-5","article-title":"High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells","volume":"49","author":"Orton","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.radonc.2025.110775_b0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","article-title":"Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain","volume":"110","author":"Milano","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.radonc.2025.110775_b0110","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2007.11.075","article-title":"The radiation dose-response of the human spinal cord","volume":"71","author":"Schultheiss","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.radonc.2025.110775_b0115","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1118\/1.4762562","article-title":"Brain necrosis after fractionated radiation therapy: is the halftime for repair longer than we thought?","volume":"39","author":"Bender","year":"2012","journal-title":"Med Phys"},{"issue":"8","key":"10.1016\/j.radonc.2025.110775_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081124","article-title":"Predicting visual acuity deterioration and radiation-induced toxicities after brachytherapy for choroidal melanomas","volume":"11","author":"Espensen","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2025.110775_b0125","unstructured":"No.38 IR, Dose and volume specification for reporting intracavitary therapy in gynecology. International Commision on Radiation Units and Measurements BM."},{"issue":"3","key":"10.1016\/j.radonc.2025.110775_b0130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0360-3016(97)00852-3","article-title":"Tolerance of rat spinal cord to continuous interstitial irradiation","volume":"40","author":"Pop","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.radonc.2025.110775_b0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0167-8140(92)90249-T","article-title":"Impact of spinal cord repair kinetics on the practice of altered fractionation schedules","volume":"25","author":"Ang","year":"1992","journal-title":"Radiother Oncol: J Eur Soc Therap Radiol Oncol"},{"issue":"13","key":"10.1016\/j.radonc.2025.110775_b0140","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S1474-4422(16)30237-X","article-title":"Diagnosis and clinical features of common optic neuropathies","volume":"15","author":"Biousse","year":"2016","journal-title":"The Lancet. Neurology"},{"issue":"6","key":"10.1016\/j.radonc.2025.110775_b0145","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00066-004-1183-8","article-title":"On the actual state of industrial quality assurance procedures with regard to (106)Ru ophthalmic plaques","volume":"180","author":"Kaulich","year":"2004","journal-title":"Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft"},{"issue":"1","key":"10.1016\/j.radonc.2025.110775_b0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2005.05.001","article-title":"Clinical quality assurance for 106Ru ophthalmic applicators","volume":"76","author":"Kaulich","year":"2005","journal-title":"Radiothe Oncol: J Eur Soc Therap Radiol Oncol"},{"issue":"10","key":"10.1016\/j.radonc.2025.110775_b0155","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS","volume":"39","author":"Chiu-Tsao","year":"2012","journal-title":"Medical physics"},{"issue":"1","key":"10.1016\/j.radonc.2025.110775_b0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2017.01.010","article-title":"Treatment plan optimization and robustness of (106)Ru eye plaque brachytherapy using a novel software tool","volume":"123","author":"Heilemann","year":"2017","journal-title":"Radiothe Oncol: J Eur Soc Therap Radiol Oncol"},{"issue":"4","key":"10.1016\/j.radonc.2025.110775_b0165","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/ceo.14070","article-title":"Scleral complications of plaque brachytherapy for pterygium and for uveal melanoma: Response","volume":"50","author":"Jabbarli","year":"2022","journal-title":"Clin Experiment Ophthalmol"},{"issue":"4","key":"10.1016\/j.radonc.2025.110775_b0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/ceo.13928","article-title":"Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors","volume":"49","author":"Jabbarli","year":"2021","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.radonc.2025.110775_b0175","article-title":"Prognostic factors for surgical treatment of radiation-induced scleral necrosis after brachytherapy for uveal melanoma","author":"Jabbarli","year":"2024","journal-title":"Eur J Ophthalmol"},{"issue":"11","key":"10.1016\/j.radonc.2025.110775_b0180","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/ICO.0000000000003483","article-title":"Surgical Outcome After Treatment of Radiation-Induced Scleral Necrosis in Patients With Uveal Melanoma","volume":"43","author":"Jabbarli","year":"2024","journal-title":"Cornea"},{"key":"10.1016\/j.radonc.2025.110775_b0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000425685","article-title":"Dosimetry and design of radioactive eye plaques","volume":"30","author":"Fl\u00fchs","year":"1997","journal-title":"Front Radiat Ther Oncol"},{"key":"10.1016\/j.radonc.2025.110775_b0190","doi-asserted-by":"crossref","unstructured":"P.K. Lommatzsch W. Alberti R. Lommatzsch F. Rohrwacher Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru\/106Rh plaques. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Aug 1994;232(8):482-487.","DOI":"10.1007\/BF00195358"},{"key":"10.1016\/j.radonc.2025.110775_b0195","doi-asserted-by":"crossref","unstructured":"Oare C, Sun S, Dusenbery K, et al. Analysis of dose to the macula, optic disc, and lens in relation to vision toxicities - A retrospective study using COMS eye plaques. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB). Sep 2022;101:71-78.","DOI":"10.1016\/j.ejmp.2022.08.001"},{"issue":"6","key":"10.1016\/j.radonc.2025.110775_b0200","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.brachy.2018.07.002","article-title":"Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review","volume":"17","author":"Le","year":"2018","journal-title":"Brachytherapy Nov-Dec"},{"issue":"2","key":"10.1016\/j.radonc.2025.110775_b0205","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.brachy.2017.11.004","article-title":"Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications","volume":"17","author":"Pagliara","year":"2018","journal-title":"Brachytherapy Mar-Apr"},{"key":"10.1016\/j.radonc.2025.110775_b0210","doi-asserted-by":"crossref","unstructured":"Kellner U, Bornfeld N, Foerster MH. Radiation-induced optic neuropathy following brachytherapy of uveal melanomas. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. May 1993;231(5):267-270.","DOI":"10.1007\/BF00919103"},{"key":"10.1016\/j.radonc.2025.110775_b0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2021.11.007","article-title":"Local tumor control and treatment related toxicity after plaque brachytherapy for uveal melanoma: A systematic review and a data pooled analysis","volume":"166","author":"Buonanno","year":"2022","journal-title":"Radiother Oncol: J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110775_b0220","doi-asserted-by":"crossref","unstructured":"The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma. Brachytherapy. Jan-Feb 2014;13(1):1-14.","DOI":"10.1016\/j.brachy.2013.11.008"},{"issue":"2","key":"10.1016\/j.radonc.2025.110775_b0225","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000479558","article-title":"Dose distributions and treatment margins in ocular brachytherapy with 106Ru eye plaques","volume":"4","author":"St\u00f6ckel","year":"2018","journal-title":"Ocular Oncol Pathol"},{"issue":"8","key":"10.1016\/j.radonc.2025.110775_b0230","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0161-6420(99)90455-4","article-title":"Risk factors for radiation maculopathy and papillopathy after intraocular irradiation","volume":"106","author":"Gragoudas","year":"1999","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.radonc.2025.110775_b0235","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11060-023-04346-y","article-title":"Outcomes of systemic bevacizumab in radiation-induced optic neuropathy, case series","volume":"163","author":"AlAmeer","year":"2023","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1016\/j.radonc.2025.110775_b0240","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.brachy.2022.08.006","article-title":"Clinical characteristics and postoperative complications as predictors of radiation toxicity after treatment with I125 Eye Plaque Brachytherapy for Uveal Melanomas","volume":"21","author":"Peters","year":"2022","journal-title":"Brachytherapy"},{"issue":"9","key":"10.1016\/j.radonc.2025.110775_b0245","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bjophthalmol-2017-311389","article-title":"Peripapillary vascular changes in radiation optic neuropathy: an optical coherence tomography angiography grading","volume":"102","author":"Parrozzani","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.radonc.2025.110775_b0250","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE): Homepage https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_60 V, last visit 07.04.2024, US Department of Health and Human Services, National Institutes of Health, National Cancer Institute."},{"key":"10.1016\/j.radonc.2025.110775_b0255","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0140-6736(04)17517-X","article-title":"The eye in neurological disease","volume":"364","author":"Miller","year":"2004","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.radonc.2025.110775_b0260","unstructured":"Visual Basic for Applications hlmcd-dovl-rcg-s-w-v-i-o, https:\/\/learn.microsoft.com\/de-de\/office\/vba\/library-reference\/concepts\/getting-started-with-vba-in-office, visited 03_2024."},{"issue":"5","key":"10.1016\/j.radonc.2025.110775_b0265","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1088\/1361-6560\/aa5696","article-title":"Monte Carlo simulation of ruthenium eye plaques with GEANT4: influence of multiple scattering algorithms, the spectrum and the geometry on depth dose profiles","volume":"62","author":"Sommer","year":"2017","journal-title":"Phys Med Biol"},{"issue":"8","key":"10.1016\/j.radonc.2025.110775_b0270","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1002\/mp.15774","article-title":"A Monte Carlo study of the relative biological effectiveness in surface brachytherapy","volume":"49","author":"Valdes-Cortez","year":"2022","journal-title":"Med Phys"},{"issue":"4","key":"10.1016\/j.radonc.2025.110775_b0275","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.zemedi.2022.07.004","article-title":"Determination of the dose rate around a HDR (192)Ir brachytherapy source with the microDiamond and the microSilicon detector","volume":"33","author":"Rossi","year":"2023","journal-title":"Z Med Phys"},{"key":"10.1016\/j.radonc.2025.110775_b0280","unstructured":"JB Walsh; JP S Garcia; JC Nieto; RB Rosen; PT Garcia; S Fradin: Wide-Angle Digital Fundus Photography: Panoret 1000 vs RetCam 120 IIo."},{"issue":"5","key":"10.1016\/j.radonc.2025.110775_b0285","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/aos.13992","article-title":"Relationship between retinal vessel diameter with both retinal nerve fibre layer thickness and optic nerve head parameters in middle-aged Caucasians: the Northern Finland Birth Cohort Eye study","volume":"97","author":"Geneid","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"10.1016\/j.radonc.2025.110775_b0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138701","article-title":"Optic disc-fovea distance, axial length and parapapillary zones. the beijing eye study 2011","volume":"10","author":"Jonas","year":"2015","journal-title":"PloS one"},{"issue":"8","key":"10.1016\/j.radonc.2025.110775_b0295","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.ophtha.2009.12.036","article-title":"Normal macular thickness measurements using optical coherence tomography in healthy eyes of adult Chinese persons: the Handan Eye Study","volume":"117","author":"Duan","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.radonc.2025.110775_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2020.106620","article-title":"Data on estimations of relative dose rates along central axis of symmetric and asymmetric 106 Ru\/ 106 Rh applicators used in eye brachytherapy","volume":"34","author":"Paiva","year":"2021","journal-title":"Data Brief"},{"issue":"6","key":"10.1016\/j.radonc.2025.110775_b0305","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1118\/1.1755471","article-title":"The design and the dosimetry of bi-nuclide radioactive ophthalmic applicators","volume":"31","author":"Fl\u00fchs","year":"2004","journal-title":"Med Phys"},{"issue":"7","key":"10.1016\/j.radonc.2025.110775_b0310","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/sim.2648","article-title":"A weighted logistic regression model for estimation of recurrence of adenomas","volume":"26","author":"Hsu","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.radonc.2025.110775_b0315","unstructured":"SAS Institute Inc. ASS, procedure HPNEURAL of SAS-Enterprise Miner 15.2, SAS-Institute, Cary, NC."},{"key":"10.1016\/j.radonc.2025.110775_b0320","doi-asserted-by":"crossref","unstructured":"Burnham KPAA, D. R. (2004). Multimodel Inference: Understanding AIC and BIC in Model Selection. In Sociological Methods and Research, 33(2), 261-304, 2004. Multimodel Inference: Understanding AIC and BIC in Model Selection. Sociological Methods and Research. 2004.","DOI":"10.1177\/0049124104268644"},{"issue":"5","key":"10.1016\/j.radonc.2025.110775_b0325","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/095530097143860","article-title":"Quantifying the position and steepness of radiation dose-response curves","volume":"71","author":"Bentzen","year":"1997","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2025.110775_b0330","doi-asserted-by":"crossref","unstructured":"Moiseenko V, Song WY, Mell LK, Bhandare N. A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy. Radiation oncology (London, England). Jun 6 2011;6:61.","DOI":"10.1186\/1748-717X-6-61"},{"issue":"1","key":"10.1016\/j.radonc.2025.110775_b0335","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0360-3016(93)90156-P","article-title":"Modeling of normal tissue response to radiation: the critical volume model","volume":"25","author":"Niemierko","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.radonc.2025.110775_b0340","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0360-3016(98)00100-X","article-title":"A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity","volume":"41","author":"Roberts","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.radonc.2025.110775_b0345","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1002\/mp.13996","article-title":"AAPM recommendations on medical physics practices for ocular plaque brachytherapy: Report of task group 221","volume":"47","author":"Thomson","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2025.110775_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110114","article-title":"GEC-ESTRO survey of (106)Ru eye applicator practice for ocular melanoma - Physicist survey","volume":"193","author":"De Brabandere","year":"2024","journal-title":"Radiother Oncol: J Eur Soc Therap Radiol Oncol"},{"issue":"8","key":"10.1016\/j.radonc.2025.110775_b0355","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1002\/mp.15045","article-title":"A Monte Carlo dose calculation system for ophthalmic brachytherapy based on a realistic eye model","volume":"48","author":"Miras Del R\u00edo","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2025.110775_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.brachy.2022.08.006","article-title":"Clinical characteristics and postoperative complications as predictors of radiation toxicity after treatment with I125 Eye Plaque Brachytherapy for Uveal Melanomas","author":"Peters","year":"2022","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.radonc.2025.110775_b0365","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamaophthalmol.2019.5132","article-title":"Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals","volume":"138","author":"Shields","year":"2020","journal-title":"JAMA Ophthalmology"},{"issue":"2","key":"10.1016\/j.radonc.2025.110775_b0370","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jamaophthalmol.2019.5122","article-title":"Studies evaluating visual outcomes after brachytherapy in uveal melanoma-strengths and limitations of current investigations","volume":"138","author":"Boldt","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.radonc.2025.110775_b0375","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2008.10.013","article-title":"I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the Collaborative Ocular Melanoma Study: COMS Report No. 30","volume":"116","author":"Boldt","year":"2009","journal-title":"Ophthalmology"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:49:18Z","timestamp":1774417758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":75,"alternative-id":["S0167814025000702"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110775","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose response relation for optic nerve atrophy at low-dose rate brachytherapy of uveal melanoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110775"}}